TRP — Tissue Repair Income Statement
0.000.00%
- AU$18.14m
- AU$5.82m
- AU$3.02m
- 48
- 35
- 47
- 39
Annual income statement for Tissue Repair, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
C2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0 | 0 | 0.003 | 0.896 | 3.02 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 0.706 | 5.45 | 5.74 | 6.67 | 7.46 |
Operating Profit | -0.706 | -5.45 | -5.74 | -5.77 | -4.44 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -0.915 | -6.84 | -4.17 | -4.14 | -4.24 |
Provision for Income Taxes | |||||
Net Income After Taxes | -0.915 | -6.84 | -4.17 | -4.14 | -4.24 |
Net Income Before Extraordinary Items | |||||
Net Income | -0.915 | -6.84 | -4.17 | -4.14 | -4.24 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -0.915 | -6.84 | -4.17 | -4.14 | -4.24 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.014 | -0.113 | -0.069 | -0.068 | -0.07 |